# OnCo record keynote-017 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/keynote-017/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "keynote-017", "NCT02267603" ;
  schema:name "KEYNOTE-017 (Cancer Immunotherapy Trials Network 09)"@en ;
  schema:description "KEYNOTE-017 showed that pembrolizumab given as the first treatment shrinks more than half of advanced Merkel cell carcinomas, whether or not the tumour carries the Merkel cell polyomavirus."@en ;
  schema:url <https://onco.cc/trials/keynote-017/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02267603>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1603702>, <https://ascopubs.org/doi/10.1200/JCO.18.01896> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/merkel-cell-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:pathways <https://onco.cc/pathways/oncogenic-viruses/> .